NYSE · Drug Manufacturers - General

LLY (LLY) Stock

$1163.29 +0.57% NYSE: LLY Healthcare

Valuation

MetricValue
Price$1163.29
Market Cap$1.10T
P/E Ratio39.87
P/B Ratio31.35
P/S Ratio14.07
EPS (TTM)$22.95
52-Week High$1292.65
52-Week Low$712.05
Dividend Yield0.58%

Financials & Margins

MetricValue
ROE92.58%
ROA18.77%
ROCE37.01%
Gross Margin45.56%
Operating Margin45.56%
Net Margin33.53%
Debt/Equity1.62
Current Ratio1.58

Annual Financials (USD)

Metric20212022202320242025
Revenue$28.3B$28.5B$34.1B$45.0B$65.2B
Operating Profit$7.9B$8.7B$10.8B$17.5B$29.7B
Net Profit$5.6B$6.2B$5.2B$10.6B$20.6B
EPS$5.85$6.57$5.80$11.71$22.95
Op Margin28.0%30.3%31.6%38.9%45.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$48.8B$49.5B$64.0B$78.7B$112.5B
Total Liabilities$39.7B$38.7B$53.1B$64.4B$85.9B
Cash$3.8B$2.1B$2.8B$3.3B$7.2B
Borrowings$16.9B$16.2B$25.2B$33.6B$42.5B

Latest News

3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026 Motley Fool · Jul 11, 2026 Should You Buy Eli Lilly Stock? Here's My Honest Take. Motley Fool · Jul 11, 2026 Eli Lilly (LLY) To Share New Kisunla And Alzheimer’s Blood Test Data At AAIC Simply Wall St. · Jul 11, 2026 Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? Motley Fool · Jul 10, 2026 Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says MT Newswires · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$7.4B$7.6B$4.2B$8.8B$16.8B
Investing Cash Flow$-4.8B$-6.7B$-14.5B$-17.7B$-18.8B
Financing Cash Flow$-1.5B$-1.8B$-1.1B$-3.0B$-4.9B
Net Cash Flow$161.0M$-1.8B$752.0M$450.0M$4.0B
Free Cash Flow$5.4B$4.6B$-3.2B$414.0M$9.0B

Valuation & Return Ratios

MetricValue
PEG Ratio0.42
EV / EBITDA33.14
FCF Yield1.79%
Quick Ratio1.00
Interest Coverage35.72
Return 1Y61.49%
Return 3Y116.48%
Return 5Y409.17%

Ownership

Insiders Held0.16%
Institutions Held85.24%
Institutions Float Held85.37%
Institutional HolderSharesReport Date
Lilly Endowment, Inc91,896,9782026-03-31
Blackrock Inc.66,380,8422026-03-31
Vanguard Capital Management LLC53,361,7742026-03-31
PNC Financial Services Group, Inc.51,328,9082026-03-31
State Street Corporation35,610,0022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABBV $261.00 +1.79% 74.06 $461.13B 2.63%
AMGN $437.27 +1.72% 27.15 $236.00B 2.29%
AZN $161.97 -0.10% 24.78 $251.19B 1.28%
GILD $149.07 +1.86% -56.96 $185.07B 2.21%
JNJ $270.06 +1.58% 31.21 $650.81B 1.99%

About LLY

LLY is led by CEO David A. Ricks, employs 47,000 people, headquartered in Indianapolis, US, publicly traded since 1972.

LLY stock trades at $1163.29 with a market capitalization of $1.10T. The stock is valued at a price-to-earnings (P/E) ratio of 39.87, price-to-book of 31.35, price-to-sales of 14.07. Over the past 52 weeks the stock has ranged between $712.05 and $1292.65, and currently trades 10.0% below its 52-week high. It pays a dividend yielding 0.58%.

On profitability, LLY generates a return on equity (ROE) of 92.58% — well above the market average, a sign of a high-quality business, return on capital employed of 37.01%, an operating margin of 45.56%, a net profit margin of 33.53%.

In its most recent fiscal year, LLY reported annual revenue of $65.2B, net profit of $20.6B, revenue has compounded at 21.6% a year over the last five years, profit at 27.2% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 1.62, a current ratio of 1.58, total assets of $112.5B, $7.2B in cash and equivalents.

LLY has a beta of 0.51 (less volatile than the overall market).

Related Healthcare Stocks

JNJ Drug Manufacturers - General $270.06 +1.58% ABBV Drug Manufacturers - General $261.00 +1.79% MRK Drug Manufacturers - General $149.18 +0.96% UNH Medical - Healthcare Plans $395.72 +1.62% NVS Drug Manufacturers - General $161.66 +6.31% AZN Drug Manufacturers - General $161.97 -0.10% AMGN Drug Manufacturers - General $437.27 +1.72% TMO Medical - Diagnostics & Research $602.27 -2.40% NVO Biotechnology $45.29 -0.09% ABT Medical - Devices $109.56 -0.72% GILD Drug Manufacturers - General $149.07 +1.86% PFE Drug Manufacturers - General $28.56 +0.36%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides